Tag: Pelage Pharmaceuticals

Pelage Pharmaceuticals has filed a notice of an exempt offering of securities to raise $119,999,987.00 in New Funding.

Pelage Pharmaceuticals has filed a notice of an exempt offering of securities to raise $119,999,987.00 in New Funding.

According to filings with the U.S. Securities and Exchange Commission, Pelage Pharmaceuticals, Inc. is raising up to $119,999,987.00 in new funding. The federal securities law requires the notice to be filed by companies that have…

Read More Read More

Pelage Pharmaceuticals Announces $120 Million Series B Financing to Advance Regenerative Medicine Treatments for Hair Loss

Pelage Pharmaceuticals Announces $120 Million Series B Financing to Advance Regenerative Medicine Treatments for Hair Loss

Financing co-led by ARCH Venture Partners and GV (Google Ventures) to support continued advancement of PP405, a topical therapy designed to reactivate dormant hair follicle stem cells to restore hair growth Positive Phase 2a results…

Read More Read More